Stanford Center for Law and the Biosciences

CRISPR’d Babies – A Discussion with Matt Porteus

Bio LawLaPaLooza 2017 | Brain I

Bio LawLaPaLooza 2017 | Other

Bio LawLaPaLooza 2017 | Genomics

How Should the U.S. Regulate Genetic Testing? | Academic Perspectives

How Should the U.S. Regulate Genetic Testing? | Pulling It Together

Bio LawLaPaLooza 2017 | Reproduction

Discussion | Human Germline Modification: Medicine, Science, Ethics, and Law

Let’s talk about CRISPR People (w/ Henry T. Greely, Stanford Center for Law and the Biosciences)

How Should the U.S. Regulate Genetic Testing? | Background Issues: The Challenges

How Should the U.S. Regulate Genetic Testing? | Professional, Patient and Payor Perspectives

Stanford Law's Hank Greely Discusses In Vitro Fertilization Post-Dobbs

How Should the U.S. Regulate Genetic Testing? | Industry Perspectives

How Should the U.S. Regulate Genetic Testing? | Government Perspectives

Bio LawLaPaLooza 2017 | Plenary: The Valentine’s Day Massacre of Genetic Romanticism

Bio LawLaPaLooza 2017 | IP

Bio LawLaPaLooza 2017 | Brain II

Hank Greely Stanford - Big Data 2014

Bio LawLaPaLooza 2017 | Government and Drugs

Bio LawLaPaLooza 2017 | Career Panel

Future Talk 59-1, Ethical Issues of New Biosciences

Panel Discussion - Human Germline Modification: Medicine, Science, Ethics, and Law

Bio LawLaPaLooza 2017 | Brain III

Future Talk #102 - Biomedical Ethics

visit shbcf.ru